Literature DB >> 29967643

The Common Clinical Presentation of Patients Selected for Septoplasty in Northern Saudi Arabia.

Abdullah D Alotaibi1, Bassam Ahmed Almutlaq2, Fahad Nashmi Alshammari3, Hussain Gadelkarim Ahmed2.   

Abstract

BACKGROUND: Nasal septal deviation (NSD) plays a critical role in nasal obstruction symptoms, aesthetic look of the nose, increased nasal resistance, and occasionally snoring. Septoplasty is the most common method for correction of deviated nasal septum (DNS). Therefore, the aim of the present study was to assess the association between initial clinical presentations of patients selected for septoplasty and demographical characteristics in Northern Saudi Arabia.
METHODOLOGY: Archives related to all patients selected for septoplasty between 2012 and 2017 were retrieved from ENT Department at King Khalid Hospital in Hail, Northern Saudi Arabia. Only adults over 18 years of age were included in this study.
RESULTS: With regard to the clinical presentations, almost all patients presented with variable degrees of nasal congestions, nasal blockages, breathing troubles, sleeping troubles, and exercise problems.
CONCLUSION: Nasal obstruction is prevalent in Northern Saudi Arabia with peaks being in the years 2016 and 2014 with the most etiological factor being DNS.

Entities:  

Year:  2018        PMID: 29967643      PMCID: PMC6008912          DOI: 10.1155/2018/8536387

Source DB:  PubMed          Journal:  Int J Otolaryngol        ISSN: 1687-9201


1. Introduction

Surgical and medical management of nasal obstruction is the common measure in otolaryngologist practice. The perfect management of deviated nasal septum (DNS) is septoplasty [1]. Chronic nasal airway obstruction is one of the most frequent complaints that patients complain of to otolaryngologists. DNS is a common anatomic disparity and the most common cause of nasal obstruction [2-4]. Surgical amendment of the DNS is the most frequent ear, nose, and throat (ENT) operation in adults [5]. Septoplasty is a surgical procedure that is done to correct a DNS. A DNS arises when the cartilage that separates the nostrils is out of place. This can cause various breathing difficulties. Septoplasty is one of the most frequently performed otorhinolaryngological procedures, which might be very challenging for many surgeons. A precise preoperative diagnosis of pathologies of the septum in the situation of the nasal cavity is crucial for the success of surgery. Intraoperative visualization through microscope or endoscope is very supportive for the surgeon and for the training of the residents. The new method of septoplasty with the phases of methodology, mobilization, resection/repositioning, and reconstruction/fixation is offered. As particularly pathologies of the caudal septum are responsible for failures of septal surgery, some special difficulties of this region such as the vertical fracture of the caudal septum, the deficiency of caudal septum, or anterior convexities of the cartilaginous septum are debated [6, 7]. Annual septoplasty rates, however, vary between countries. More than 20,000 septoplasties, (3.8 septoplasties per 10,000 inhabitants) were done in England between 2012 and 2013 [8]. In spite of the significant number of septoplasties achieved each year, complications after this process are relatively rare. Most complications result from insufficient surgical preparation or poor performance and often can be avoided. Surgeons should discuss these risks with patients before surgery as part of the informed consent process [9]. Patients selected for septoplasty present with diverse clinical presentations, particularly those with DNS. The occurrence of these clinical presentations may differ in association with demographical features of patients in specific population. Therefore, the aim of the present study was to assess the association between initial clinical presentations of patients selected for septoplasty and demographical characteristics in Northern Saudi Arabia.

2. Materials and Methods

This study involved 131 patients that presented with nasal obstruction and that were subsequently selected for septoplasty. Archives related to all selected patients for septoplasty between 2012 and 2017 were retrieved from ENT Department at King Khalid Hospital in Hail, Northern Saudi Arabia. Only adults over 18 years of age were included in this study. Patients' medical records were investigated, and patients with a history of rhinoplasty, cranial and facial trauma, or bone deformity (except DNS) and patients with mass in the nasal cavity were excluded from the study. Several nasal obstruction related clinical presentations were recorded, including nasal congestion, nasal blockages, breathing troubles, sleeping troubles, and exercise problems. Demographical characteristics including age, gender, and residence were also recorded. Patients were assigned to septoplasty (with or without concurrent turbinate surgery) and the procedure was performed within 3 to 5 weeks after final surgical treatment choice.

3. Ethical Consent

Our study protocol conformed with the 2013 Declaration of Helsinki and this study was approved by the ethics committee of the College of Medicine, University of Hail, Saudi Arabia.

4. Statistical Analysis

Statistical analysis was performed using SPSS software for Windows (version 16.0, SPSS Inc., Chicago, IL, USA). Categorical variables are given as frequencies and percentages, as well as continuous variables. For all statistical comparisons, a p value below 0.05 was considered statistically significant.

5. Results

The present study investigated retrospectively 131 consecutive cases of nasal blockages related abnormalities, their ages ranging from 18 to 42 years, with a mean age of 26 years. Most of the patients were 21–25 years old, followed by age ranges 36–30, <20 years, and 31–35 years, representing 43, 28, 27, and 19, respectively, as indicated in Table 1 and Figure 1. The majority of males were found at age group 21–25 years followed by 26–30 and 31–35 years constituting 29, 26, and 17, respectively. The majority of females were found at age group 21–25 years, followed by <20 years constituting 14 and 11 correspondingly, as indicated in Table 1 and Figures 1 and 2.
Table 1

Study subjects by demographical characteristics.

VariableCategoryMalesFemalesTotal
Year of Diagnosis
2012415
2013415
2014161026
201523427
201638947
201714721
Total9932131
Age groups
<20 years161127
21–25291443
26–3026228
31–3517219
36+11314
Occupations
Employees23124
Teachers16218
Students291645
Solders909
Medicals112
others211233
Figure 1

Description of the study population by age, year of admission, and occupations.

Figure 2

Description of the study population by gender and demographical characteristics.

Out of 131 patients, 99/131 (75.6%) were males and 32/131 (24.4%) were females, giving male-to-female ratio of 3.09 to 1.00. The majority of the patients were registered in the year 2016 followed by years 2015, 2014, 2017, 2012, and 2013, representing 47 (35.9%), 27 (20.6%), 26 (19.8%), 21 (16.1%), and 5 (3.8%), respectively. For males, most of them presented in the year 2016 followed by years 2015, 2014, 2017, 2013, and 2012, constituting 38/99 (38.4%), 23/99 (23.2%), 16/99 (16.2%), 14/99 (14%), and 4/99 (4.1%), respectively. For females, most of them presented in the year 2014 followed by years 2016 and 2017, representing 10/32 (31%), 9/32 (28.2%), and 7/32 (19%), in this order, as shown in Table 1 and Figures 1 and 2. With regard to the occupations, the majority of the patients were students representing 45/131 (34.4%) followed by others, employees, teachers, and soldiers, constituting 33 (25.2%), 24 (18.3%), 18 (13.7%), and 9 (6.8%), in this order. For males, the great majority were students followed by employees and others representing 29/99 (29.3%), 23 (23.2%), and 21 (21.2%), correspondingly. For females, the majority were students followed by others, constituting 16/32 (50%) and 12 (37.5%), respectively, as indicated in Table 1 and Figures 1 and 2. With regard to the clinical presentations, almost all patients presented with variable degrees of nasal congestions, nasal blockages, breathing troubles, sleeping troubles, and exercise problems. For nasal congestions, 17 (13%), 30 (22.9%), and 62 (47.3%) of the patients presented with mild, moderate, and severe nasal congestions, respectively. For nasal blockages, 15 (11.5%), 26 (19.8%), and 82 (62.6%) of the patients presented with mild, moderate, and severe nasal blockages. For breathing troubles, 17 (13%), 27 (20.6%), and 70 (53.4%) of the patients presented with mild, moderate, and severe breathing trouble. For sleeping troubles, 20 (15.3%), 20 (15.3%), and 70 (53.4%) of the patients presented with mild, moderate, and severe sleeping troubles. For exercise troubles, 31 (26.7%), 28 (21.3%), and 34 (26%) of the patients presented with mild, moderate, and severe exercise troubles, as indicated in Table 2 and Figure 3.
Table 2

Distribution of the study subjects by clinical presentations.

VariableNo MildModerateSevereTotal
Nasal congestions22173062131
Nasal blockages8152682131
Breathing troubles17172770131
Sleeping troubles21202070131
Exercise problems38312834131
Figure 3

Description of patients by initial clinical presentation.

Table 3 summarizes the distribution of the study subjects by gender and clinical presentations. Out of 82 male patients that presented with nasal congestions, 11/82 (13.4%), 23 (28%), and 48 (58.5%) of the patients presented with mild, moderate, and severe nasal congestions, respectively, and the relative risk (RR) (95% confidence interval, 95% CI) was 0.98 (0.8311 to 1.1736). Out of 27 female patients that presented with nasal congestions, 6/27 (22.2%), 7 (26%), and 14 (51.8%) of the patients presented with mild, moderate, and severe nasal congestions, respectively, as indicated in Table 3 and Figure 4.
Table 3

Distribution of the study subjects by gender and clinical presentations.

VariableCategoryNoMildModerateSevereRR (95% CI)
Nasal congestions
Males171123480.98 (0.8311 to 1.1736)
Females56714
Nasal blockages
Males6819660.96 (0.2058 to 4.5683)
Females27716
Breathing troubles
Males111122551.09 (0.9148 to 1.3116)
Females66515
Sleeping troubles
Males151315561.04 (0.8670 to 1.2579)
Females67514
Exercise problems
Males262520281.17 (0.8802 to 1.5815)
Females12686
Figure 4

Description of patients by initial clinical presentations and gender.

Out of 93 male patients that presented with nasal blockages, 8/93 (8.6%), 19 (20.4%), and 66 (71%) of the patients presented with mild, moderate, and severe nasal blockages, respectively, and the RR (95% CI) was 0.96 (0.2058 to 4.5683). Out of 30 female patients that presented with nasal blockages, 7/30 (23.3%), 7 (23.3%), and 16 (53.3%) of the patients presented with mild, moderate, and severe nasal blockages, respectively, as indicated in Table 3 and Figure 4. Out of 88 male patients that presented with breathing troubles, 11/88 (12.5%), 22 (26%), and 55 (62.5%) of the patients presented with mild, moderate, and severe breathing troubles, respectively, and the RR (95% CI) was 1.09 (0.9148 to 1.3116). Out of 26 female patients that presented with breathing troubles, 6/26 (23%), 5 (19.2%), and 15 (58%) of the patients presented with mild, moderate, and severe breathing troubles, respectively, as indicated in Table 3 and Figure 4. Out of 84 male patients that presented with sleeping troubles, 13/84 (15.5%), 15 (18%), and 56 (66.7%) of the patients presented with mild, moderate, and severe sleeping troubles, respectively, and the RR (95% CI) was 1.04 (0.8670 to 1.2579). Out of 26 female patients that presented with sleeping trouble, 7/26 (27%), 5 (19.2%), and 14 (53.8%) presented with mild, moderate, and severe sleeping troubles, respectively, as indicated in Table 3 and Figure 4. Out of 73 male patients that presented with exercise problems, 25/73 (34%), 20 (27.4%), and 28 (38.4%) of the patients presented with mild, moderate, and severe exercise problems, respectively, and the RR (95% CI) was 1.17 (0.8802 to 1.5815). Out of 20 female patients that presented with sleeping troubles, 6/20 (30%), 8 (40%), and 6 (30%) of the patients presented with mild, moderate, and severe exercise problem, respectively, as indicated in Table 3 and Figure 4. The distribution of the study subjects by age and clinical presentations is summarized in Table 4. Most of the cases with severe nasal congestions were found among age group 26–30 years followed by age range 21–25 representing 17/62 (27.4%) and 16/62 (25.8%), respectively; hence, the cases with moderate degree were found among age group 21–25 years followed by age group <20 years constituting 14/30 (46.7%) and 5/30 (16.7%), in this order.
Table 4

Distribution of the study subjects by age and clinical presentations.

VariableCategoryNoMildModerateSevereTotal
Nasal congestions
<20 years2851227
21–25121141643
26–305331728
31–352341019
36+124714
Total22173062131
Nasal blockages
<20 years2091627
21–253882443
26–30134228
31–351231319
36+122914
Breathing troubles
<20 years5361327
21–256762443
26–304241828
31–35226919
36+035614
Sleeping troubles
<20 years5341527
21–258971943
26–305261528
31–35343919
36+0201214
Exercise problems
<20 years1265427
21–25126121343
26–30696728
31–35644519
36+261514
Most of the cases with severe nasal blockages were found among age group 21–25 years followed by age group <20 representing 24/62 (38.7%) and 16/62 (25.8%), respectively; hence, most of the cases with moderate degree were found among age group <20 years followed by age group 21–25 years constituting 9/30 (30%) and 8/30 (26.7%), in this order, as indicated in Table 4. Most of the cases with severe breathing troubles were found among age group 21–25 years followed by age group 26–30 representing 24/62 (38.7%) and 18/62 (29%), respectively; hence, most of the cases with moderate degree were found among age group 21–25 years followed by <20 years constituting 7/30 (23.3%) and 3/30 (10%), in this order, as indicated in Table 4. Most of the cases with severe sleeping troubles were found among age group 21–25 years followed by age group 26–30 representing 19/62 (30.6%) and 15/62 (24.2%), respectively; hence, most of the cases with moderate degree were found among age group 21–25 years followed by 26–30 years constituting 7/30 (23.3%) and 6/30 (20%), in this order, as indicated in Table 4. Most of the cases with severe exercise problems were found among age group 21–25 years followed by 26–30 representing 13/62 (21%) and 7/62 (11.3%), respectively; hence, most of the cases with moderate degree were found among age group 21–25 years followed by 26–30 years constituting 12/30 (40%) and 6/30 (20%), in this order, as indicated in Table 4. The distribution of the study subjects by occupations and clinical presentations is summarized in Table 4. The majority of patients with severe nasal congestions were found among students followed by others constituting 19/62 (30.6%) and 16 (25.8%) correspondingly, whereas the majority of cases with moderate condition were identified among students and employees representing 9/30 (30%) and 8 (26.7%), respectively. The majority of patients with severe nasal blockages were found among students followed by others constituting 29/62 (46.8%) and 19 (30.6%) correspondingly, whereas the majority of cases with moderate conditions were identified among students and employees representing 11/30 (36.7%) and 6 (20%), respectively, as indicated in Table 5.
Table 5

Distribution of the study subjects by occupation and clinical presentation.

VariableCategoryNoMildModerateSevereTotal
Nasal congestions
Employees3281124
Teachers1141218
Students9891945
Solders22149
Medicals01102
Others7371633
Nasal blockages
Employees0261624
Teachers0321318
Students23112945
Solders11259
Medicals01102
Others5541933
Breathing troubles
Employees2361324
Teachers1141218
Students55102545
Solders22239
Medicals11002
Others6551733
Sleeping troubles
Employees2151624
Teachers1421118
Students8672545
Solders11259
Medicals01102
Others9731433
Exercise problems
Employees565824
Teachers525518
Students17981145
Solders34119
Medicals10102
Others7108833
The majority of patients with severe breathing troubles were found among students followed by others constituting 25/62 (40.3%) and 17 (27.4%) correspondingly, whereas the majority of cases with moderate conditions were identified among students and employees representing 10/30 (33.3%) and 6 (20%), respectively, as indicated in Table 5. The majority of patients with severe sleeping troubles were found among students followed by employees constituting 25/62 (40.3%) and 16 (%) correspondingly, whereas the majority of cases with moderate conditions were identified among students and employees representing 7/30 (23.3%) and 5 (16.7%), respectively, as indicated in Table 5. The majority of patients with severe exercise problems were found among students followed by employees constituting 25/62 (40.3%) and 16 (25.8%) correspondingly, whereas the majority of cases with moderate conditions were identified among students and others representing 8/30 (26.7%) and 8 (26.7%), respectively, as indicated in Table 5. Out of 131 patients, 112 (85.5%) were diagnosed with DNS and the remaining 19 (14.5%) were found with conditions other than DNS. All of the patients were selected for septoplasty. Out of 99 males, 87 (87.9%) were found with DNS; hence, out of 32 females, 25 (78%) were found with DNS.

6. Discussion

Nasal obstruction is a common problem, which is caused by several factors with the greatest being DNS. The nasal septum has a vital role in both the look and function of the nose. Deviation of the nose is reciprocal and amendment needs an attentive, anatomically based treatment. Therefore, the present study focused on the association between initial clinical presentation (mainly nasal obstruction) of patients selected for septoplasty and demographical characteristics in Northern Saudi Arabia. In the present study, out of 131 patients with nasal obstruction, about 76% were males and only 24% were females. DNS is a very prevalent condition in several parts of the world, with severe symptoms such as nasal obstruction and rhinitis. Although some studies have showed similar results to our findings that DNS is more prevalent in men [10, 11], some epidemiology studies reported that women have nearly double the rate of chronic rhinosinusitis (CRS) when compared with men [12, 13], whereas other studies found no difference [11, 14]. Studies from Saudi Arabia have shown that DNS is more common among males than females [15]. In the present study, DNS was more common in age range 21 to 29 years. Although diverse studies reported varying percentages with mostly age mean around 30 years old, similar results have been previously reported [16, 17]. The great majority of the cases in this series were reported in the year 2016 followed by year 2014. Although in our extensive search regarding the epidemiology of DNS we did not come across a study that compares the prevalence of DNA in different years, singly scattered reports from Saudi Arabia were relatively comparable to our findings [17, 18]. Annual septoplasty rates, however, differ between countries. More than 20,000 septoplasties, i.e., 3.8 septoplasties per 10,000 inhabitants, were performed in England between 2012 and 2013[8]. In the Netherlands, 10,000 septoplasties, i.e., 6.0 septoplasties per 10,000 inhabitants, were performed as a single procedure or in combination with turbinate surgery in 2010 [19]. With regard to occupations, most of the patients were students followed by employees. However, not all of our study population were cases of DNS; some were cases of nasal obstruction due to other etiological factors. Reversible nasal congestion is usually caused by mucosal inflammation and secretions. In contrast, fixed or relatively constant congestion (i.e., obstruction) may be due to occlusion (e.g., nasal polyps, foreign body), anatomical variation (e.g., septal deformity, turbinate hypertrophy), or, rarely, neoplasm. In some cases, abnormal sensory perception may also contribute to a patient's perception of nasal congestion. A differential diagnosis of reversible nasal congestion includes allergic rhinitis, nonallergic rhinitis, vasomotor rhinitis, exaggerated nasal cycle, acute viral rhinitis, acute viral rhinosinusitis, acute bacterial rhinitis, acute bacterial rhinosinusitis, chronic inflammatory or infectious rhinosinusitis, rhinitis medicamentosa, sarcoidosis, Wegener's granulomatosis, Churg–Strauss syndrome, and rhinoscleroma [20]. In the present study, approximately 85.5% of the patients presented with DNS. Similar findings were previously reported in diverse studies. In a study that investigated the correlation of nasal septal deviations and chronic rhinosinusitis, DNS was found in 49 (81.7%) subjects; 11 (18.3%) had it in both right and left sides, 16 (26.7%) in the right side alone, and 22 (36.7%) in the left side. The commonest types of septal deviations in the left side were posteroinferior (10, 16.66%) and anteroinferior (7, 11.7%). In the right side, the corresponding numbers were 9 (15%) and 7 (11.7%) [21]. Some studies have reported nasal septal deviation in 20–31% of the community and also revealed that severe deviation predisposed the individuals to rhinosinusitis [22, 23]. Nasal septoplasty is one of the most common procedures in otolaryngology owing to the high prevalence of nasal obstruction from septal deviation [24]. As stressed in the literature, identification of the C- and S-shaped deformities at the time of planning remains crucial for identifying potentially complex surgeries compared to less technically challenging operative interventions such as septal tilts [25, 26]. Conclusion. Nasal obstruction is prevalent in Northern Saudi Arabia with peaks being in the years 2016 and 2014 with the most etiological factor being DNS. DNS is commonly seen among men in Northern Saudi Arabia and most patients underwent septoplasty in their twenties. Septoplasty has a good prospect to be accepted as a quick practice, with patient effective perioperative care being the basis of good outcomes.
  19 in total

Review 1.  [Septoplasty update].

Authors:  I Baumann
Journal:  Laryngorhinootologie       Date:  2010-06-10       Impact factor: 1.057

2.  Prevalence and risk factors of chronic sinusitis in Korea: results of a nationwide survey.

Authors:  Y G Min; H W Jung; H S Kim; S K Park; K Y Yoo
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 3.  Septoplasty: Basic and Advanced Techniques.

Authors:  Sam P Most; Shannon F Rudy
Journal:  Facial Plast Surg Clin North Am       Date:  2017-02-21       Impact factor: 1.918

4.  Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study.

Authors:  D Hastan; W J Fokkens; C Bachert; R B Newson; J Bislimovska; A Bockelbrink; P J Bousquet; G Brozek; A Bruno; S E Dahlén; B Forsberg; M Gunnbjörnsdóttir; L Kasper; U Krämer; M L Kowalski; B Lange; B Lundbäck; E Salagean; A Todo-Bom; P Tomassen; E Toskala; C M van Drunen; J Bousquet; T Zuberbier; D Jarvis; P Burney
Journal:  Allergy       Date:  2011-05-24       Impact factor: 13.146

5.  Recent trends in utilization of procedures in otolaryngology-head and neck surgery.

Authors:  P D Manoukian; J R Wyatt; D A Leopold; E B Bass
Journal:  Laryngoscope       Date:  1997-04       Impact factor: 3.325

6.  A new classification of septal deviations.

Authors:  Ingo Baumann; Helmut Baumann
Journal:  Rhinology       Date:  2007-09       Impact factor: 3.681

7.  Epidemiology and burden of nasal congestion.

Authors:  Michael Stewart; Bj Ferguson; Len Fromer
Journal:  Int J Gen Med       Date:  2010-04-08

8.  Nasal soft tissue obstruction improvement after septoplasty without turbinectomy.

Authors:  Yasser Haroon; Hala Aly Saleh; Ahmed H Abou-Issa
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-01       Impact factor: 2.503

9.  Common nasal deformities among rhinoplasty patients in a university hospital in Saudi Arabia.

Authors:  Sami Alharethy; Turki Aldrees; Reem Aljrid; Abdullah Alanazi; Saleh K Algaryan; Yong Ju Jang
Journal:  Ann Saudi Med       Date:  2017 May-Jun       Impact factor: 1.526

10.  Radiological sinonasal anatomy. Exploring the Saudi population.

Authors:  Redha A Alrumaih; Mona M Ashoor; Ahmed A Obidan; Khulood M Al-Khater; Saeed A Al-Jubran
Journal:  Saudi Med J       Date:  2016-05       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.